Health authorities have confirmed the first case of H3N2 influenza in Latin America, with the detection of the virus in Mexico on Friday, December 12th. Commonly referred to as “supergripa,” this strain has been circulating in Europe,North America and parts of Asia,and its arrival in the region is prompting increased vigilance from public health organizations. While officials state the clinical presentation is consistent with seasonal flu, the confirmation underscores the need for continued monitoring and preventative measures, particularly vaccination against influenza, COVID-19, and pneumococcal disease.
Las autoridades sanitarias confirmaron el primer caso de influenza H3N2 en América Latina, un hecho que marca la llegada de esta variante a la región y refuerza la atención de los organismos de salud frente a su comportamiento reciente.
Conocida popularmente como la “supergripa”, esta cepa había sido reportada hasta ahora en Europa, Norteamérica y algunos países de Asia, por lo que su detección en territorio latinoamericano amplía el mapa de circulación del virus.
Tras la confirmación del contagio, los sistemas de salud activaron medidas de seguimiento y fortalecieron la vigilancia epidemiológica, con el fin de monitorear posibles nuevos casos y evaluar su impacto en la región.
Se expande el contagio
La llegada del virus a the region was confirmed after the National Institute of Respiratory Diseases reported the first case of influenza H3N2 subclade K in Mexico on Friday, December 12.
According to the country’s Health Secretariat, the patient was treated as an outpatient, received antiviral medications, and has since recovered.
This confirmation came just hours after authorities indicated that no cases of this variant had been identified, highlighting the dynamic nature of epidemiological monitoring.
Despite the detection of the case, health officials clarified that the clinical management of this variant is similar to that of seasonal influenza and that, at this time, no extraordinary measures have been issued. This news comes as public health agencies worldwide continue to monitor influenza strains and their potential impact.
The Secretariat also reiterated that the primary preventative measure remains vaccination. They urged citizens to visit health centers and receive available vaccines against influenza, COVID-19 and pneumococcus.
“These vaccines are effective in reducing risks, preventing complications and hospitalizations, and protecting health. Especially for girls and boys, older adults, pregnant women, healthcare personnel and people with comorbidities,” the statement reads.
Síntomas frecuentes del H3N2
According to international scientific reviews, symptoms of H3N2 typically appear suddenly. The most common symptoms include:
- High fever accompanied by chills
- Sore throat
- Nasal discharge
- Muscle and headache
- Intense fatigue
- Persistent dry cough
In more complex cases, the virus can lead to pneumonia, acute respiratory distress, or other complications, especially in people with pre-existing health conditions. Experts recommend consulting a doctor if symptoms persist or health status worsens. The emergence of this variant underscores the importance of staying informed about circulating influenza strains and seeking timely medical care when needed.
